Prevalence and factors associated with physical function limitation in older West African people living with HIV

Although physical function decline is common with aging, the burden of this impairment remains underestimated in patients living with HIV (PLHIV), particularly in the older people receiving antiretroviral treatment (ART) and living in sub-Saharan Africa (SSA). PLHIV aged ≥50 years old and on ART sin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2020-10, Vol.15 (10), p.e0240906
Hauptverfasser: Bernard, Charlotte, Font, Hélène, Diallo, Zélica, Ahonon, Richard, Tine, Judicaël Malick, Abouo, Franklin, Tanon, Aristophane, Messou, Eugène, Seydi, Moussa, Dabis, François, de Rekeneire, Nathalie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page e0240906
container_title PloS one
container_volume 15
creator Bernard, Charlotte
Font, Hélène
Diallo, Zélica
Ahonon, Richard
Tine, Judicaël Malick
Abouo, Franklin
Tanon, Aristophane
Messou, Eugène
Seydi, Moussa
Dabis, François
de Rekeneire, Nathalie
description Although physical function decline is common with aging, the burden of this impairment remains underestimated in patients living with HIV (PLHIV), particularly in the older people receiving antiretroviral treatment (ART) and living in sub-Saharan Africa (SSA). PLHIV aged ≥50 years old and on ART since ≥6 months were included (N = 333) from three clinics (two in Côte d'Ivoire, one in Senegal) participating in the International epidemiological Databases to Evaluate AIDS (IeDEA) West Africa collaboration. Physical function was measured using the Short Physical Performance Battery (SPPB), the unipodal balance test and self-reported questionnaires. Grip strength was also assessed. Logistic regression was used to identify the factors associated with SPPB performance specifically. Median age was 57 (54-61) years, 57.7% were female and 82.7% had an undetectable viral load. The mean SPPB score was 10.2 ±1.8. Almost 30% had low SPPB performance with the 5-sit-to-stand test being the most altered subtest (64%). PLHIV with low SPPB performance also had significantly low performance on the unipodal balance test (54.2%, p = 0.001) and low mean grip strength (but only in men (p = 0.005)). They also showed some difficulties in daily life activities (climbing stairs, walking one block, both p
doi_str_mv 10.1371/journal.pone.0240906
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2453677514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A639142794</galeid><doaj_id>oai_doaj_org_article_3f6ab9aeda2d449eb2e8885954eba6b6</doaj_id><sourcerecordid>A639142794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c726t-1fad41a0ff0b975445fa867165c5aaa1906f2f759fc0486b442edd952c5966823</originalsourceid><addsrcrecordid>eNqNk19v0zAUxSMEYmPwDRBEQkLsocWOHSd-QaomYJUqDfFnPFo3jt16cu3MTgr79jhtN63THlAeYt38zrF9cm-WvcZoikmFP175ITiw0847NUUFRRyxJ9kx5qSYsAKRp_fWR9mLGK8QKknN2PPsiBDEMWL4OOu-BbUBq5xUObg21yB7H2IOMXppoFdt_sf0q7xb3UQjweZ6cLI33uXWrE0P26VxubetCvlvFft8pkMiXd4p31mVuI1xy53L-fzyZfZMg43q1f59kv368vnn2flkcfF1fjZbTGRVsH6CNbQUA9IaNbwqKS011KzCrJQlAOB0WV3oquRaIlqzhtJCtS0vC1lyxuqCnGRvd76d9VHsw4qioCVhVVVimoj5jmg9XIkumDWEG-HBiG3Bh6WA0BtplSCaQcNBtVC0lHLVFKqu65KXVDXAGpa8Pu13G5q1aqVyfQB7YHr4xZmVWPqNqMoa1fV4mNOdweqB7Hy2EGMNEYx4TegGJ_bDfrPgr4cUuVibKJW14JQftnekmJCao4S-e4A-nsSeWqZOEMZpn84oR1MxY4RjWlR8pKaPUOlp1drI1IXapPqB4PRAkJhe_e2XMMQo5j--_z97cXnIvr_HrhTYfhW9HcZejIcg3YEy-BiD0nfJYiTGIbpNQ4xDJPZDlGRv7v_MO9Ht1JB_Hp4W5A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2453677514</pqid></control><display><type>article</type><title>Prevalence and factors associated with physical function limitation in older West African people living with HIV</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Bernard, Charlotte ; Font, Hélène ; Diallo, Zélica ; Ahonon, Richard ; Tine, Judicaël Malick ; Abouo, Franklin ; Tanon, Aristophane ; Messou, Eugène ; Seydi, Moussa ; Dabis, François ; de Rekeneire, Nathalie</creator><contributor>Mayne, Elizabeth S.</contributor><creatorcontrib>Bernard, Charlotte ; Font, Hélène ; Diallo, Zélica ; Ahonon, Richard ; Tine, Judicaël Malick ; Abouo, Franklin ; Tanon, Aristophane ; Messou, Eugène ; Seydi, Moussa ; Dabis, François ; de Rekeneire, Nathalie ; IeDEA West Africa Cohort Collaboration ; The IeDEA West Africa Cohort Collaboration ; Mayne, Elizabeth S.</creatorcontrib><description>Although physical function decline is common with aging, the burden of this impairment remains underestimated in patients living with HIV (PLHIV), particularly in the older people receiving antiretroviral treatment (ART) and living in sub-Saharan Africa (SSA). PLHIV aged ≥50 years old and on ART since ≥6 months were included (N = 333) from three clinics (two in Côte d'Ivoire, one in Senegal) participating in the International epidemiological Databases to Evaluate AIDS (IeDEA) West Africa collaboration. Physical function was measured using the Short Physical Performance Battery (SPPB), the unipodal balance test and self-reported questionnaires. Grip strength was also assessed. Logistic regression was used to identify the factors associated with SPPB performance specifically. Median age was 57 (54-61) years, 57.7% were female and 82.7% had an undetectable viral load. The mean SPPB score was 10.2 ±1.8. Almost 30% had low SPPB performance with the 5-sit-to-stand test being the most altered subtest (64%). PLHIV with low SPPB performance also had significantly low performance on the unipodal balance test (54.2%, p = 0.001) and low mean grip strength (but only in men (p = 0.005)). They also showed some difficulties in daily life activities (climbing stairs, walking one block, both p&lt;0.0001). Age ≥60 years (adjusted OR (aOR) = 3.4; CI95% = 1.9-5.9,), being a female (aOR = 2.1; CI95% = 1.1-4.1), having an abdominal obesity (aOR = 2.1; CI95% = 1.2-4.0), a longer duration of HIV infection (aOR = 2.9; CI95% = 1.5-5.7), old Nucleoside reverse transcriptase inhibitors (NRTIs) (i.e., AZT: zidovudine, ddI: didanosine, DDC: zalcitabine, D4T: stavudine) in current ART (aOR = 2.0 CI95% = 1.1-3.7) were associated with low SPPB performance. As in western countries, physical function limitation is now part of the burden of HIV disease complications of older PLHIV living in West Africa, putting this population at risk for disability. How to screen those impairments and integrate their management in the standards of care should be investigated, and specific research on developing adapted daily physical activity program might be conducted.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0240906</identifier><identifier>PMID: 33091061</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Aged ; Aged, 80 and over ; Aging ; Anti-HIV Agents - therapeutic use ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Balance ; Biology and Life Sciences ; Body mass index ; Chronic illnesses ; Complications ; Complications and side effects ; Cote d'Ivoire - epidemiology ; Cross-Sectional Studies ; Didanosine ; Disabilities ; Disease ; Distribution ; Epidemiology ; Exercise ; Female ; Grip strength ; HIV ; HIV infections ; HIV Infections - drug therapy ; HIV Infections - physiopathology ; Hospitals ; Human immunodeficiency virus ; Humans ; Infections ; Life Sciences ; Male ; Medical research ; Medicine and Health Sciences ; Middle age ; Middle Aged ; Nucleoside reverse transcriptase inhibitors ; Obesity ; Older people ; Patients ; Physical activity ; Physical Functional Performance ; Population ; Postural Balance - physiology ; Prevalence ; Risk Factors ; RNA-directed DNA polymerase ; Santé publique et épidémiologie ; Self Report ; Senegal - epidemiology ; Standard of Care ; Stavudine ; Tropical diseases ; Zalcitabine ; Zidovudine</subject><ispartof>PloS one, 2020-10, Vol.15 (10), p.e0240906</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Bernard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Attribution</rights><rights>2020 Bernard et al 2020 Bernard et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c726t-1fad41a0ff0b975445fa867165c5aaa1906f2f759fc0486b442edd952c5966823</citedby><cites>FETCH-LOGICAL-c726t-1fad41a0ff0b975445fa867165c5aaa1906f2f759fc0486b442edd952c5966823</cites><orcidid>0000-0003-2677-4023 ; 0000-0002-1614-8857</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580884/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580884/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79472,79473</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33091061$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03109834$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Mayne, Elizabeth S.</contributor><creatorcontrib>Bernard, Charlotte</creatorcontrib><creatorcontrib>Font, Hélène</creatorcontrib><creatorcontrib>Diallo, Zélica</creatorcontrib><creatorcontrib>Ahonon, Richard</creatorcontrib><creatorcontrib>Tine, Judicaël Malick</creatorcontrib><creatorcontrib>Abouo, Franklin</creatorcontrib><creatorcontrib>Tanon, Aristophane</creatorcontrib><creatorcontrib>Messou, Eugène</creatorcontrib><creatorcontrib>Seydi, Moussa</creatorcontrib><creatorcontrib>Dabis, François</creatorcontrib><creatorcontrib>de Rekeneire, Nathalie</creatorcontrib><creatorcontrib>IeDEA West Africa Cohort Collaboration</creatorcontrib><creatorcontrib>The IeDEA West Africa Cohort Collaboration</creatorcontrib><title>Prevalence and factors associated with physical function limitation in older West African people living with HIV</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Although physical function decline is common with aging, the burden of this impairment remains underestimated in patients living with HIV (PLHIV), particularly in the older people receiving antiretroviral treatment (ART) and living in sub-Saharan Africa (SSA). PLHIV aged ≥50 years old and on ART since ≥6 months were included (N = 333) from three clinics (two in Côte d'Ivoire, one in Senegal) participating in the International epidemiological Databases to Evaluate AIDS (IeDEA) West Africa collaboration. Physical function was measured using the Short Physical Performance Battery (SPPB), the unipodal balance test and self-reported questionnaires. Grip strength was also assessed. Logistic regression was used to identify the factors associated with SPPB performance specifically. Median age was 57 (54-61) years, 57.7% were female and 82.7% had an undetectable viral load. The mean SPPB score was 10.2 ±1.8. Almost 30% had low SPPB performance with the 5-sit-to-stand test being the most altered subtest (64%). PLHIV with low SPPB performance also had significantly low performance on the unipodal balance test (54.2%, p = 0.001) and low mean grip strength (but only in men (p = 0.005)). They also showed some difficulties in daily life activities (climbing stairs, walking one block, both p&lt;0.0001). Age ≥60 years (adjusted OR (aOR) = 3.4; CI95% = 1.9-5.9,), being a female (aOR = 2.1; CI95% = 1.1-4.1), having an abdominal obesity (aOR = 2.1; CI95% = 1.2-4.0), a longer duration of HIV infection (aOR = 2.9; CI95% = 1.5-5.7), old Nucleoside reverse transcriptase inhibitors (NRTIs) (i.e., AZT: zidovudine, ddI: didanosine, DDC: zalcitabine, D4T: stavudine) in current ART (aOR = 2.0 CI95% = 1.1-3.7) were associated with low SPPB performance. As in western countries, physical function limitation is now part of the burden of HIV disease complications of older PLHIV living in West Africa, putting this population at risk for disability. How to screen those impairments and integrate their management in the standards of care should be investigated, and specific research on developing adapted daily physical activity program might be conducted.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Balance</subject><subject>Biology and Life Sciences</subject><subject>Body mass index</subject><subject>Chronic illnesses</subject><subject>Complications</subject><subject>Complications and side effects</subject><subject>Cote d'Ivoire - epidemiology</subject><subject>Cross-Sectional Studies</subject><subject>Didanosine</subject><subject>Disabilities</subject><subject>Disease</subject><subject>Distribution</subject><subject>Epidemiology</subject><subject>Exercise</subject><subject>Female</subject><subject>Grip strength</subject><subject>HIV</subject><subject>HIV infections</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - physiopathology</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Middle age</subject><subject>Middle Aged</subject><subject>Nucleoside reverse transcriptase inhibitors</subject><subject>Obesity</subject><subject>Older people</subject><subject>Patients</subject><subject>Physical activity</subject><subject>Physical Functional Performance</subject><subject>Population</subject><subject>Postural Balance - physiology</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>RNA-directed DNA polymerase</subject><subject>Santé publique et épidémiologie</subject><subject>Self Report</subject><subject>Senegal - epidemiology</subject><subject>Standard of Care</subject><subject>Stavudine</subject><subject>Tropical diseases</subject><subject>Zalcitabine</subject><subject>Zidovudine</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk19v0zAUxSMEYmPwDRBEQkLsocWOHSd-QaomYJUqDfFnPFo3jt16cu3MTgr79jhtN63THlAeYt38zrF9cm-WvcZoikmFP175ITiw0847NUUFRRyxJ9kx5qSYsAKRp_fWR9mLGK8QKknN2PPsiBDEMWL4OOu-BbUBq5xUObg21yB7H2IOMXppoFdt_sf0q7xb3UQjweZ6cLI33uXWrE0P26VxubetCvlvFft8pkMiXd4p31mVuI1xy53L-fzyZfZMg43q1f59kv368vnn2flkcfF1fjZbTGRVsH6CNbQUA9IaNbwqKS011KzCrJQlAOB0WV3oquRaIlqzhtJCtS0vC1lyxuqCnGRvd76d9VHsw4qioCVhVVVimoj5jmg9XIkumDWEG-HBiG3Bh6WA0BtplSCaQcNBtVC0lHLVFKqu65KXVDXAGpa8Pu13G5q1aqVyfQB7YHr4xZmVWPqNqMoa1fV4mNOdweqB7Hy2EGMNEYx4TegGJ_bDfrPgr4cUuVibKJW14JQftnekmJCao4S-e4A-nsSeWqZOEMZpn84oR1MxY4RjWlR8pKaPUOlp1drI1IXapPqB4PRAkJhe_e2XMMQo5j--_z97cXnIvr_HrhTYfhW9HcZejIcg3YEy-BiD0nfJYiTGIbpNQ4xDJPZDlGRv7v_MO9Ht1JB_Hp4W5A</recordid><startdate>20201022</startdate><enddate>20201022</enddate><creator>Bernard, Charlotte</creator><creator>Font, Hélène</creator><creator>Diallo, Zélica</creator><creator>Ahonon, Richard</creator><creator>Tine, Judicaël Malick</creator><creator>Abouo, Franklin</creator><creator>Tanon, Aristophane</creator><creator>Messou, Eugène</creator><creator>Seydi, Moussa</creator><creator>Dabis, François</creator><creator>de Rekeneire, Nathalie</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2677-4023</orcidid><orcidid>https://orcid.org/0000-0002-1614-8857</orcidid></search><sort><creationdate>20201022</creationdate><title>Prevalence and factors associated with physical function limitation in older West African people living with HIV</title><author>Bernard, Charlotte ; Font, Hélène ; Diallo, Zélica ; Ahonon, Richard ; Tine, Judicaël Malick ; Abouo, Franklin ; Tanon, Aristophane ; Messou, Eugène ; Seydi, Moussa ; Dabis, François ; de Rekeneire, Nathalie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c726t-1fad41a0ff0b975445fa867165c5aaa1906f2f759fc0486b442edd952c5966823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Balance</topic><topic>Biology and Life Sciences</topic><topic>Body mass index</topic><topic>Chronic illnesses</topic><topic>Complications</topic><topic>Complications and side effects</topic><topic>Cote d'Ivoire - epidemiology</topic><topic>Cross-Sectional Studies</topic><topic>Didanosine</topic><topic>Disabilities</topic><topic>Disease</topic><topic>Distribution</topic><topic>Epidemiology</topic><topic>Exercise</topic><topic>Female</topic><topic>Grip strength</topic><topic>HIV</topic><topic>HIV infections</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - physiopathology</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Middle age</topic><topic>Middle Aged</topic><topic>Nucleoside reverse transcriptase inhibitors</topic><topic>Obesity</topic><topic>Older people</topic><topic>Patients</topic><topic>Physical activity</topic><topic>Physical Functional Performance</topic><topic>Population</topic><topic>Postural Balance - physiology</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>RNA-directed DNA polymerase</topic><topic>Santé publique et épidémiologie</topic><topic>Self Report</topic><topic>Senegal - epidemiology</topic><topic>Standard of Care</topic><topic>Stavudine</topic><topic>Tropical diseases</topic><topic>Zalcitabine</topic><topic>Zidovudine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bernard, Charlotte</creatorcontrib><creatorcontrib>Font, Hélène</creatorcontrib><creatorcontrib>Diallo, Zélica</creatorcontrib><creatorcontrib>Ahonon, Richard</creatorcontrib><creatorcontrib>Tine, Judicaël Malick</creatorcontrib><creatorcontrib>Abouo, Franklin</creatorcontrib><creatorcontrib>Tanon, Aristophane</creatorcontrib><creatorcontrib>Messou, Eugène</creatorcontrib><creatorcontrib>Seydi, Moussa</creatorcontrib><creatorcontrib>Dabis, François</creatorcontrib><creatorcontrib>de Rekeneire, Nathalie</creatorcontrib><creatorcontrib>IeDEA West Africa Cohort Collaboration</creatorcontrib><creatorcontrib>The IeDEA West Africa Cohort Collaboration</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bernard, Charlotte</au><au>Font, Hélène</au><au>Diallo, Zélica</au><au>Ahonon, Richard</au><au>Tine, Judicaël Malick</au><au>Abouo, Franklin</au><au>Tanon, Aristophane</au><au>Messou, Eugène</au><au>Seydi, Moussa</au><au>Dabis, François</au><au>de Rekeneire, Nathalie</au><au>Mayne, Elizabeth S.</au><aucorp>IeDEA West Africa Cohort Collaboration</aucorp><aucorp>The IeDEA West Africa Cohort Collaboration</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and factors associated with physical function limitation in older West African people living with HIV</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2020-10-22</date><risdate>2020</risdate><volume>15</volume><issue>10</issue><spage>e0240906</spage><pages>e0240906-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Although physical function decline is common with aging, the burden of this impairment remains underestimated in patients living with HIV (PLHIV), particularly in the older people receiving antiretroviral treatment (ART) and living in sub-Saharan Africa (SSA). PLHIV aged ≥50 years old and on ART since ≥6 months were included (N = 333) from three clinics (two in Côte d'Ivoire, one in Senegal) participating in the International epidemiological Databases to Evaluate AIDS (IeDEA) West Africa collaboration. Physical function was measured using the Short Physical Performance Battery (SPPB), the unipodal balance test and self-reported questionnaires. Grip strength was also assessed. Logistic regression was used to identify the factors associated with SPPB performance specifically. Median age was 57 (54-61) years, 57.7% were female and 82.7% had an undetectable viral load. The mean SPPB score was 10.2 ±1.8. Almost 30% had low SPPB performance with the 5-sit-to-stand test being the most altered subtest (64%). PLHIV with low SPPB performance also had significantly low performance on the unipodal balance test (54.2%, p = 0.001) and low mean grip strength (but only in men (p = 0.005)). They also showed some difficulties in daily life activities (climbing stairs, walking one block, both p&lt;0.0001). Age ≥60 years (adjusted OR (aOR) = 3.4; CI95% = 1.9-5.9,), being a female (aOR = 2.1; CI95% = 1.1-4.1), having an abdominal obesity (aOR = 2.1; CI95% = 1.2-4.0), a longer duration of HIV infection (aOR = 2.9; CI95% = 1.5-5.7), old Nucleoside reverse transcriptase inhibitors (NRTIs) (i.e., AZT: zidovudine, ddI: didanosine, DDC: zalcitabine, D4T: stavudine) in current ART (aOR = 2.0 CI95% = 1.1-3.7) were associated with low SPPB performance. As in western countries, physical function limitation is now part of the burden of HIV disease complications of older PLHIV living in West Africa, putting this population at risk for disability. How to screen those impairments and integrate their management in the standards of care should be investigated, and specific research on developing adapted daily physical activity program might be conducted.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33091061</pmid><doi>10.1371/journal.pone.0240906</doi><tpages>e0240906</tpages><orcidid>https://orcid.org/0000-0003-2677-4023</orcidid><orcidid>https://orcid.org/0000-0002-1614-8857</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2020-10, Vol.15 (10), p.e0240906
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2453677514
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Aged
Aged, 80 and over
Aging
Anti-HIV Agents - therapeutic use
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Balance
Biology and Life Sciences
Body mass index
Chronic illnesses
Complications
Complications and side effects
Cote d'Ivoire - epidemiology
Cross-Sectional Studies
Didanosine
Disabilities
Disease
Distribution
Epidemiology
Exercise
Female
Grip strength
HIV
HIV infections
HIV Infections - drug therapy
HIV Infections - physiopathology
Hospitals
Human immunodeficiency virus
Humans
Infections
Life Sciences
Male
Medical research
Medicine and Health Sciences
Middle age
Middle Aged
Nucleoside reverse transcriptase inhibitors
Obesity
Older people
Patients
Physical activity
Physical Functional Performance
Population
Postural Balance - physiology
Prevalence
Risk Factors
RNA-directed DNA polymerase
Santé publique et épidémiologie
Self Report
Senegal - epidemiology
Standard of Care
Stavudine
Tropical diseases
Zalcitabine
Zidovudine
title Prevalence and factors associated with physical function limitation in older West African people living with HIV
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A30%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20factors%20associated%20with%20physical%20function%20limitation%20in%20older%20West%20African%20people%20living%20with%20HIV&rft.jtitle=PloS%20one&rft.au=Bernard,%20Charlotte&rft.aucorp=IeDEA%20West%20Africa%20Cohort%20Collaboration&rft.date=2020-10-22&rft.volume=15&rft.issue=10&rft.spage=e0240906&rft.pages=e0240906-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0240906&rft_dat=%3Cgale_plos_%3EA639142794%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2453677514&rft_id=info:pmid/33091061&rft_galeid=A639142794&rft_doaj_id=oai_doaj_org_article_3f6ab9aeda2d449eb2e8885954eba6b6&rfr_iscdi=true